Tumors obtained from patients with high-grade serous ovarian cancer (HGSOC) undergoing cytoreductive surgery were subjected to analysis of cellular senescence biomarkers, that is, SA-β-Gal and γ-H2A.X, and proliferative antigen, Ki67. The gene discussed is MKI67; the disease is ovarian serous adenocarcinoma.